Literature DB >> 30974501

Six-month outcomes after restrictive or liberal transfusion for cardiac surgery (TRICS III trial).

L J Estcourt1,2, D J Roberts1,2.   

Abstract

CLINICAL QUESTION: Is transfusing red cell components using a restrictive transfusion threshold (Hb < 75 g L-1 ) as safe as a liberal transfusion threshold (Hb < 95 g L-1 in intensive care and < 85 g L-1 outside intensive care) during and after cardiac surgery for adults at moderate to high risk of death? EVIDENCE FROM TRIAL: In adults undergoing cardiac surgery who were at moderate to high risk for death, using a restrictive red-cell transfusion threshold was as safe as a liberal red cell transfusion threshold (composite outcome of death from any cause, myocardial infarction, stroke or new-onset renal failure with dialysis at 6 months after surgery).
© 2019 British Blood Transfusion Society.

Entities:  

Keywords:  cardiac surgery; randomised-controlled trial; red cell transfusions

Mesh:

Year:  2019        PMID: 30974501     DOI: 10.1111/tme.12596

Source DB:  PubMed          Journal:  Transfus Med        ISSN: 0958-7578            Impact factor:   2.019


  1 in total

1.  Restricting Red-Cell Transfusions in Cardiac Surgery: No Increase in AKI.

Authors:  Iain C Macdougall; Toby Richards
Journal:  J Am Soc Nephrol       Date:  2019-06-20       Impact factor: 10.121

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.